Pregled bibliografske jedinice broj: 1131464
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview // Pharmacogenomics and Personalized Medicine, 14 (2021), 631-653 doi:10.2147/pgpm.s284615 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1131464 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Personalizing the Care and Treatment of
Alzheimer’s Disease: An Overview
Autori
Švob Štrac, Dubravka ; Konjevod, Marcela ; Sagud, Marina ; Nikolac Perković, Matea ; Nedić Erjavec, Gordana ; Vuić, Barbara ; Šimić, Goran ; Vukić, Vana ; Mimica, Ninoslav ; Pivac, Nela
Izvornik
Pharmacogenomics and Personalized Medicine (1178-7066) 14
(2021);
631-653
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Alzheimer disease ; epigenetics ; gut microbiota ; precision medicine ; therapy
Sažetak
Alzheimer's disease (AD) is a progressive, complex, and multifactorial neurodegenerative disorder, still without effective and stable therapeutic strategies. Currently, available medications for AD are based on symptomatic therapy, which include acetylcholinesterase (AChE) inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonist. Additionally, medications such as antipsychotic drugs, antidepressants, sedative, and hypnotic agents, and mood stabilizers are used for the management of behavioral and psychological symptoms of dementia (BPSD). Clinical research has been extensively investigated treatments focusing on the hallmark pathology of AD, including the amyloid deposition, tau hyperphosphorylation, neuroinflammation, and vascular changes ; however, so far without success, as all new potential drugs failed to show significant clinical benefit. The underlying heterogeneous etiology and diverse symptoms of AD suggest that a precision medicine strategy is required, which would take into account the complex genetic, epigenetic, and environmental landscape of each AD patient. The article provides a comprehensive overview of the literature on AD, the current and potential therapy of both cognitive symptoms as well as BPSD, with a special focus on gut microbiota and epigenetic modifications as new emerging drug targets. Their specific patterns could represent the basis for novel individually tailored approaches aimed to optimize precision medicine strategies for AD prevention and treatment. However, the successful application of precision medicine to AD demands a further extensive research of underlying pathological processes, as well as clinical and biological complexity of this multifactorial neurodegenerative disorder.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2019-04-6100 - Terapijski potencijal neurosteroida i neurotrofina u demenciji (TePoNeDe) (Švob Štrac, Dubravka, HRZZ - 2019-04) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb
Profili:
Marcela Konjevod
(autor)
Goran Šimić
(autor)
Dubravka Švob Štrac
(autor)
Matea Nikolac Perković
(autor)
Ninoslav Mimica
(autor)
Gordana Nedić Erjavec
(autor)
Barbara Vuić
(autor)
Marina Šagud
(autor)
Nela Pivac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus